U.S. market Closed. Opens in 3 hours 41 minutes

AGE | AgeX Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue142.00K34.00K144.00K1.87M1.73M1.40M1.40M
Cost of Revenue171.00K13.00K19.00K158.00K244.00K364.00K168.00K
Gross Profit-29.00K21.00K125.00K1.71M1.48M1.03M1.24M
Operating Expenses9.93M7.00M8.16M12.38M14.04M12.28M9.65M
Selling, General & Admin9.33M5.97M6.71M7.40M8.14M5.65M3.87M
Research & Development603.00K1.02M1.46M4.98M5.90M6.63M5.78M
Other Operating Expenses11.00K13.00K448.00K44.00K294.00K183.00KN/A
Operating Income-9.96M-6.97M-8.04M-10.67M-12.56M-11.24M-6.66M
Other Expenses / Income-4.85M-3.55M-543.00K-455.00K323.00K3.40M26.00K
Before Tax Income-14.81M-10.52M-8.58M-11.13M-12.24M-7.73M-6.64M
Income Tax Expenses-8.00K152.00K1.64M-150.00K148.00K3.51MN/A
Net Income-14.80M-10.67M-10.22M-10.98M-12.38M-7.50M-6.58M
Interest Expenses4.90M3.33M1.10M-499.00KN/A116.00KN/A
Basic Shares Outstanding1.08M1.08M1.08M1.07M1.06M34.91M35.80M
Diluted Shares Outstanding1.08M1.08M1.08M1.07M1.06M34.91M35.80M
EBITDA-9.83M-6.83M-7.46M-8.99M-11.61M-10.71M-5.90M
EBITDA Margin-6,921.83%-20,088.24%-5,180.56%-481.21%-671.76%-767.19%-420.09%
EBIT-9.91M-7.19M-7.49M-11.62M-12.24M-3.87M-6.58M
EBIT Margin-6,979.58%-21,138.24%-5,197.92%-622.32%-708.10%-277.36%-468.66%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙